Since MDSCs are significant contributors to the immunosuppressive PDAC TME and CXCR2 is important for their recruitment to the PDAC TME, CXCR2 is an attractive target for pancreatic cancer. This evidence concerns the gene CXCR2 and familial pancreatic carcinoma.